|
1
|
Zhang YQ: Pathological and clinical
analysis of IgA nephropathy. Zhong Guo Xian Dai Yi Yao Za Zhi.
17:722010.[(In Chinese)].
|
|
2
|
Yang DS, Luo CG, Jiang WM, et al:
Observation of efficacy of combination therapy with Leflunomide and
hormone on IgA nephropathy. Zhong Guo Xian Dai Yi Yao Za Zhi.
17:74–75. 2010.[(In Chinese)].
|
|
3
|
Li LS and Liu ZH: Epidemiologic data of
renal diseases from a single unit in China: analysis based on
13,519 renal biopsies. Kidney Int. 66:920–923. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Barratt J and Feehally J: IgA nephropathy.
J Am Soc Nephrol. 16:2088–2097. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen XM and Xie YS: Attach importance to
basic and clinical research on the postponement of progression of
IgA nephropathy. Chin J Nephrol. 20:235–237. 2004.[(In
Chinese)].
|
|
6
|
Yu XQ, Li M, Zhang H, Low HQ, Wei X, Wang
JQ, Sun LD, Sim KS, Li Y, et al: A genome-wide association study in
Han Chinese identifies multiple susceptibility loci for IgA
nephropathy. Nat Genet. 44:178–182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu HH, Chu KH, Yang YH, et al: Genetics
and immunopathogenesis of IgA nephropathy. Clin Rev Allergy
Immunol. 41:198–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kiryluk K, Julian BA, Wyatt RT, et al:
Genetic studies of IgA nephropathy: past, present, and future.
Pediatr Nephrol. 25:2257–2268. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang H, Sui W, Xue W, Wu J, Chen J and Dai
Y: Univariate and multiple linear regression analyses for 23 single
nucleotide polymorphisms in 14 genes predisposing to chronic
glomerular diseases and IgA nephropathy in Han Chinese. Saudi J
Kidney Dis Transpl. 25:992–997. 2014.PubMed/NCBI
|
|
10
|
Xu R, Feng S, Li Z, Fu Y, et al:
Polymorphism of DEFA hinese Han population with IgA nephropathy.
Hum Genet. 133:1299–1309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mao S, Ren X, Huang S and Zhang A:
Association of megsin 2093C/T, 2180C/T and C25663G gene
polymorphism with the risk of IgA nephropathy. Ren Fail.
36:817–822. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li GS, Zhu L, Zhang H, et al: Variants of
the ST6GALNAC2 promoter influence transcriptional activity and
contribute to genetic susceptibility to IgA nephropathy. Hum Mutat.
28:950–957. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zou WZ: Guidance on renal biopsy
pathologic diagnostic criteria. Chin J Nephrol. 17:270–275.
2001.[(In Chinese)].
|
|
14
|
Zhu B, Zhu CF, Lin Y, Perkovic V, et al:
Clinical characteristics of IgA nephropathy associated with low
complement 4 levels. Ren Fail. 1–9. Dec 24–2014.(Epub ahead of
print).
|
|
15
|
Shimozato S, Hiki Y, Odani H, Takahashi K,
Yamamoto K and Sugiyama S: Serum under-galactosylated IgA1 is
increased in Japanese patients with IgA nephropathy. Nephrol Dial
Transplant. 23:1931–1939. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gharavi AG, Moldoveanu Z, Wyatt RJ, Barker
CV, Woodford SY, et al: Aberrant IgA1 glycosylation is inherited in
familial and sporadic IgA nephropathy. J Am Soc Nephrol.
19:1008–1014. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin XJ, Ding JX, Zhu L, et al: Aberrant
galactosylation of IgA1 is involved in the genetic susceptibility
of Chinese patients with IgA nephropathy. Nephrol Dial Transplant.
24:3372–3375. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gharavi AG, Moldoveanu Z, Wyatt RJ, et al:
Aberrant IgAl glycosylation is inherited in familial and sporadic
IgA nephropathy. J Am Soc Nephrol. 19:1008–1014. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patsos G, Hebbe-Viton V, Robbe-Masselot C,
et al: O-glycan inhibitors generate aryl-glycans, induce apoptosis
and lead to growth inhibition in colorectal cancer cell lines.
Glycobiology. 19:382–398. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ding JX, Xu LX, Lv JC, et al: Aberrant
sialylation of serum IgA1 was associated with prognosis of patients
with IgA nephropathy. Clin Immunol. 125:268–274. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu L, Ding JX, Lv JC, et al: Expression
of ST6GALNAC2 gene in B lymphocytes is influenced in Epstein-Barr
virus transformation. Chinese Journal of Nephrology. 24:130–133.
2008.[(In Chinese)].
|
